| Connor James Dering, | |
|
1 Greenwood Ave, Montclair, NJ 07042-3649 | |
| (973) 746-2424 | |
| (973) 746-5030 |
| Full Name | Connor James Dering |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 7 Years |
| Location | 1 Greenwood Ave, Montclair, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124544259 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 40QA01739600 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ivyrehab Network Inc | 3476539776 | 442 |
News Archive
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
In rodents with type 2 diabetes, a single surgical injection of a protein called fibroblast growth factor 1 can restore blood sugar levels to normal for weeks or months. Yet how this growth factor acts in the brain to generate this lasting benefit has been poorly understood.
Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.
Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.
Studies in older children and adults show that the most effective long-term control medicine for persistent asthma (symptoms more than two days a week or more than twice a month at night) is inhaled corticosteroids, which reduce airway swelling and help prevent asthma symptoms (e.g., asthma attacks).
› Verified 3 days ago
| Provider Name | Ivyrehab Network Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1861623753 PECOS PAC ID: 3476539776 Enrollment ID: O20040628000865 |
News Archive
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
In rodents with type 2 diabetes, a single surgical injection of a protein called fibroblast growth factor 1 can restore blood sugar levels to normal for weeks or months. Yet how this growth factor acts in the brain to generate this lasting benefit has been poorly understood.
Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.
Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.
Studies in older children and adults show that the most effective long-term control medicine for persistent asthma (symptoms more than two days a week or more than twice a month at night) is inhaled corticosteroids, which reduce airway swelling and help prevent asthma symptoms (e.g., asthma attacks).
› Verified 3 days ago
| Provider Name | Professional Occupational & Physical Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1215487772 PECOS PAC ID: 3779873401 Enrollment ID: O20170118000654 |
News Archive
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
In rodents with type 2 diabetes, a single surgical injection of a protein called fibroblast growth factor 1 can restore blood sugar levels to normal for weeks or months. Yet how this growth factor acts in the brain to generate this lasting benefit has been poorly understood.
Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.
Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.
Studies in older children and adults show that the most effective long-term control medicine for persistent asthma (symptoms more than two days a week or more than twice a month at night) is inhaled corticosteroids, which reduce airway swelling and help prevent asthma symptoms (e.g., asthma attacks).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Connor James Dering, 77 Park Ave Apt 1614, Hoboken, NJ 07030-7116 Ph: (732) 977-1756 | Connor James Dering, 1 Greenwood Ave, Montclair, NJ 07042-3649 Ph: (973) 746-2424 |
News Archive
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
In rodents with type 2 diabetes, a single surgical injection of a protein called fibroblast growth factor 1 can restore blood sugar levels to normal for weeks or months. Yet how this growth factor acts in the brain to generate this lasting benefit has been poorly understood.
Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.
Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.
Studies in older children and adults show that the most effective long-term control medicine for persistent asthma (symptoms more than two days a week or more than twice a month at night) is inhaled corticosteroids, which reduce airway swelling and help prevent asthma symptoms (e.g., asthma attacks).
› Verified 3 days ago
Ms. Barbara Carol Foley, P.T., F.P. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 232 Grove St, Montclair, NJ 07042 Phone: 973-746-9415 | |
Shaun Astorga, Physical Therapist Medicare: Medicare Enrolled Practice Location: 15 Bloomfield Ave, Montclair, NJ 07042 Phone: 973-744-2770 | |
Ms. Laura Ann Crandall, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 267 Park St, Montclair, NJ 07043 Phone: 973-744-8205 | |
Ms. Suzanne Goodman, MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 19 Elm St, Montclair, NJ 07042 Phone: 973-798-6800 Fax: 973-798-6801 | |
Professional Orthopedic And Sports Physical Therapy Of Nj, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 691 Bloomfield Ave, Montclair, NJ 07042 Phone: 973-893-5082 | |
David Kwon, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 15 Bloomfield Ave, Lower Level, Montclair, NJ 07042 Phone: 973-744-2770 | |
Michael Joseph Habersaat, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 Greenwood Ave, Montclair, NJ 07042 Phone: 973-746-2424 |